trending Market Intelligence /marketintelligence/en/news-insights/trending/tr1asZadOIuc7GAO8AdypQ2 content esgSubNav
In This List

Halo Labs acquires Precisa Medical Instruments

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Halo Labs acquires Precisa Medical Instruments

Halo Labs Inc. has acquired private company Precisa Medical Instruments Corp. for 13,392,857 Halo shares valued at 28 Canadian cents apiece.

Switzerland-based Precisa's product portfolio includes the Accu-Dab cannabinoid oil delivery system, used to take measured doses of the oil for oral consumption.

In June, Halo signed a nonbinding letter of intent to acquire Lesotho-based Bophelo Bioscience & Wellness (Pty.) Ltd.

Toronto-based Halo Labs manufactures cannabis oils and concentrates and operates in the U.S.